The company’s equity raise to recapitalise its balance sheet was oversubscribed, raising $23.9m.
Revenue and profit grows at infant formula marketer, but no news on deployment of $1b cash balance.
The wool carpet maker has initiated strategic review amid buyer interest.
The ASX-listed company behind a biomass project needs more than $300m to develop a plant at Kawerau.
Australian media report Zuru co-founder was weighing bid for NZ Herald publisher.
‘Someone else can have sleepless nights and check the weather forecast at 4am to see if there’s a frost in Martinborough.’
Low expectations for earnings will turn attention to company forecasts.
Shareholders in Chemist Warehouse, previously privately owned, now own 85% of the bulked up Sigma Healthcare.
CEO Greg Foran and chair Dame Therese Walsh grilled at select committee.
The NZX-listed company is taking its time to think carefully how it adapts to the US imposing higher tariffs on Chinese imports.